Infections and immunodeficiency in Down syndrome

Clinical and Experimental Immunology

Volumn 164, Issue 1, 2011, Pages 9-16

  Ram, G ^a   Chinen, J ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Antibody response; Chemotaxis; Down syndrome; Immunodeficiency; Otitis media

Indexed keywords

ADAPTIVE IMMUNITY; ALLERGY; ANTIBODY RESPONSE; ANTIBODY TITER; ASPIRATION PNEUMONIA; BORDETELLA BRONCHISEPTICA; CHRONIC RHINITIS; DISEASE ASSOCIATION; DISEASE COURSE; DOWN SYNDROME; EAR MALFORMATION; GASTROESOPHAGEAL REFLUX; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; INNATE IMMUNITY; MORAXELLA CATARRHALIS; MORBIDITY; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; STREPTOCOCCUS PNEUMONIAE;

CHILD; DOWN SYNDROME; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOPENIA; MODELS, IMMUNOLOGICAL; RESPIRATORY TRACT INFECTIONS;

EID: 79952495602     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04335.x     Document Type: Review

References (84)

1. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002; 359:1019-25.
2. Canfield MA, Honein MA, Yuskiv N, Xing J, Mai CT, Collins JS. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1990-2001. Birth Defects Res A Clin Mol Teratol 2006; 76:747-56.
3. van Trotsenburg AS, Heymans HS, Tijssen JG, de Vijlder JJ, Vulsma T. Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome. Pediatrics 2006; 118:1633-9.
4. Zachor DA, Mroczek-Musulman E, Brown P. Prevalence of celiac disease in Down syndrome in the United States. J Pediatr Gastroenterol Nutr 2000; 31:275-9.
5. Sanchez-Albisua I, Storm W, Wascher I, Stern M. How frequent is celiac disease in Down syndrome. Eur J Pediatr 2002; 161: 683-4.
6. Goldacre M, Wotton C, Seagroatt V, Yeates D. Cancers and immune related diseases associated with Down Syndrome: a record linkage study. Arch Dis Child 2004; 89:1014-17.
7. Turner S, Sloper P, Cunningham C, Knussen C. Health problems in children with Down's syndrome. Child Care Health Dev 1990; 16:83-97.
8. Selikowitz M. Health problems and health checks in school-aged children with Down syndrome. J Pediatr Child Health 1992; 28:383-6.
9. Burgio GR, Ugazio AG, Nespoli L, Marcioni AF, Bottelli AM, Pasquali F. Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages. Eur J Immunol 1975; 5:600-3.
10. Burgio GR, Lanzavecchia A, Maccario R, Vitiello A, Plebani A, Ugazio AG. Immunodeficiency in Down's syndrome: T lymphocyte subset imbalance in trisomic children. Clin Exp Immunol 1978; 33:298-301.
11. Cruz NV, Mahmoud SA, Chen H, Lowery-Nordberg M, Berlin K, Bahna SL. Follow up study of immune defects in patients with dysmorphic disorders. Ann Allergy Asthma Immunol 2009; 102:426-31.
12. Hilton JM, Fitzgerald DA, Cooper DM. Respiratory morbidity of hospitalized children with trisomy 21. J Pediatr Child Health 1999; 35:383-6.
13. Bloemers BL, van Furth AM, Weijerman ME etal. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis - a prospective birth-cohort study. Pediatrics 2007; 120:1076-81.
14. Bloemers BL, van Furth AM, Weijerman ME etal. High incidence of recurrent wheeze in children with Down syndrome with and without previous respiratory syncytial virus lower respiratory tract infection. Pedatric Inf Dis J 2010; 29:39-42.
15. Megged O, Schlesinger Y. Down syndrome and respiratory sincytial virus infection. Pediatr Infect Dis 2010; 29:672-3.
16. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004; 23:824-8.
17. Don M, Canciani M, Korppi M. Community-acquired pneumonia in children: what's old? What's new? Acta Paediatr 2010; 99:1602-8.
18. Bruijn M, van der Aa LB, van Rijn RR, Bos AP, van Woensel JB. High incidence of acute lung injury in children with Down syndrome. Intens Care Med 2007; 33:2179-82.
19. Jovanovic SV, Clements D, MacLeod K. Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic Biol Med 1998; 25:1044-8.
20. Hill DA, Gridley G, Cnattinguius S etal. Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 2003; 163:705-11.
21. Garrison M, Jeffries H, Christakis D. Risk of death for children with Down syndrome and sepsis. J Pediatr 2005; 147:748-52.
22. Morgan J. Why is periodontal disease more prevalent and more severe in people with Down syndrome? Spec Care Dentist 2007; 27:196-201.
23. Kusters MAA, Verstgen RHJ, Gemen EFA, deVries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol 2009; 156:189-93.
24. de Hingh YC, Van der Vossen PW, Gemen EF etal. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 2005; 147:744-7.
25. Cocchi G, Mastrocola M, Capelli M, Bastelli A, Vitali F, Corvaglia L. Immunological patterns in young children with Down syndrome: is there a temporal trend? Acta Paediatr 2007; 96:1479-82.
26. Murphy M, Epstein L. Down syndrome (trisomy 21) thymuses have a decreased proportion of cells expressing high levels of TCR alpha, beta and CD3. Clin Immunol Immunopathol 1990; 55:453-67.
27. Murphy M, Epstein L. Down syndrome peripheral blood contains phenotypically mature CD3 TCR alpha beta cells but abnormal proportions of TCR gamma delta, TCR alpha beta and CD4+45RA+ cells: evidence for an inefficient release of mature T cells by DS thymus. Clin Immunol Immunopathol 1992; 62:245-51.
28. Barrena MJ, Echaniz P, Garcia-Serrano C, Cuadrado E. Imbalance of the CD4 subpopulations expressing CD45RA and CD29 antigens in the peripheral blood of adults and children with Down syndrome. Scand J Immunol 1993; 38:323-6.
29. Prada N, Nasi M, Troiano L etal. Direct analysis of thymic function in children with Down syndrome. Immun Aging 2005; 2:1-8.
30. Kusters MA, Gemen EF, Vestergen RH, Wever PC, DeVries E. Both normal memory counts and decreased naïve cells favor intrinsic defect over early senescence of Down syndrome lymphocytes. Pediatr Res 2010; 67:557-62.
31. Verstegen RH, Kusters MA, Gemen EF, deVries E. Down syndrome B-lymphocyte populations, intrinsic defect or decreased T lymphocyte help. Pediatr Res 2010; 67:563-6.
32. Rigas D, Elsasser P, Hecht F. Impaired in vitro response of circulating lymphocytes to phytohemagglutinin in Down's syndrome: dose and time-response curves and relation to cellular immunity. Int Allergy Immunol 1970; 39:587-608.
33. Cetiner S, Dermirhan O, Inal TC, Tastermir D, Sertdemir Y. Analysis of peripheral blood T cell subset, natural killer cells and serum levels of cytokines in children with Down syndrome. Int J Immunogenet 2010; 37:233-7.
34. Loh RK, Harth SC, Thing YH, Ferrante A. Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome. Pediatr Infect Dis J 1990; 9:547-51.
35. Mehta PD, Dalton AJ, Mehta SP, Percy ME, Sersen EA, Wisniewski HM. Immunoglobulin G subclasses in older persons with Down syndrome. J Neurol Sci 1993; 117:186-91.
36. Chaushu S, Chaushu G, Zigmond M etal. Age-dependent deficiency in saliva and salivary antibodies secretion in Down's syndrome. Arch Oral Biol 2007; 52:1088-96.
37. Lopez V, Ochs HD, Thuline HC, Davis SD, Wedgwood RJ. Defective antibody response to bacteriophage phi 174 in Down syndrome. J Pediatr 1975; 86:207-11.
38. Hawkes RA, Philbrook SC, Boughton CR. The response of institutionalized Down's syndrome subjects to enterovirus infections. J Hyg 1980; 84:433-41.
39. Li Volti S, Mattina T, Mauro L etal. Safety and effectiveness of an acellular pertussis vaccine in subjects with Down's syndrome. Child Nerv Syst 1996; 12:100-2.
40. Epstein L, Phillip R. Abnormalities in the immune response to influenza antigen in Down syndrome (trisomy 21). Prog Clin Biol Res 1987; 246:163-82.
41. Avanzini M, Monafo V, De Amici M etal. Humoral immunodeficiency in Down syndrome: serum IgG subclass and antibody response to hepatitis B vaccine. Am J Med Genet 1990; 7:231-3.
42. Ferreira CT, Leite JC, Taniguchi A, Vieira SM, Pereira-Lima J, da Silveira TR. Immunogenicity and safety of an inactivated hepatitis A vaccine in children with Down syndrome. J Pediatr Gastroenterol Nutr 2004; 39:337-40.
43. Nurmi T, Leinonen M, Häivä VM, Tiilikainen A, Kouvalainen K. Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down's syndrome). Clin Exp Immunol 1982; 48:485-90.
44. Costa-Carvalho BT, Martinez RM, Dias AT etal. Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Braz J Med Biol Res 2006; 39:1587-92.
45. Khan AJ, Evans HE, Glass L, Skin YH, Almonte D. Defective neutrophil chemotaxis in patients with Down syndrome. J Pediatr 1975; 87:87-9.
46. Barkin RM, Weston WL, Humbert JR, Maire F. Phagocytic function in Down syndrome - I. Chemotaxis. J Ment Defic Res 1980; 24:243-9.
47. Barroeta O, Nungaray L, López-Osuna M, Armendares S, Salamanca F, Kretschmer RR. Defective monocyte chemotaxis in children with Down's syndrome. Pediatr Res 1983; 17:292-5.
48. Costello C, Webber A. White cell function in Down's syndrome. Clin Genet 1976; 9:603-5.
49. Barkin RM, Weston WL, Humbert JR, Sunada K. Phagocytic function in Down syndrome - II. Bactericidal activity and phagocytosis. J Ment Defic Res 1980; 24:251-6.
50. Taylor GM, Haugh H, Williams A, D'Souza SW, Harris R. Down's syndrome lymphoid cell lines exhibit increased adhesion due to the over-expression of lymphocyte function-associated antigen (LFA-1). Immunology 1988; 64:451-6.
51. Robson AJ, Taylor GM, D'Souza SW. Monoclonal antibodies to CD18 and CD11a distinguish Down's syndrome (trisomy 21) from normal lymphoblastoid cells. Dis Markers 1989; 7:169-80.
52. Novo E, Garcia MI, Lavergne J. Nonspecific immunity in Down syndrome: a study of chemotaxis, phagocytosis, oxidative metabolism, and cell surface expression of polymorphonuclear cells. Am J Med Genet 1983; 46:384-91.
53. Barrena MJ, Echaniz P, Garcia-Serrano C, Zubillaga P, Cuadrado E. Differential expression of lymphocyte function-associated antigen (LFA-1) on peripheral blood leucocytes from individuals with Down's syndrome. Clin Exp Immunol 1992; 88:41-4.
54. Feaster WW, Kwok LW, Epstein CJ. Dosage effects for superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21.Am. J Hum Genet 1977; 29:563-70.
55. Cossarizza A, Ortolani C, Forti E etal. Age-related expansion of functionally inefficient cells with markers of natural killer cells activity in Down's syndrome. Blood 1991; 77:1263-70.
56. Guazzarotti L, Trabattoni D, Castelletti E etal. T lymphocyte maturation is impaired in healthy young individuals carrying trisomy 21 (Down syndrome). Am J Intellect Dev Disabil 2009; 114:100-9.
57. Nisihara RM, Utiyama SR, Oliveira NP, Messias-Reason IJ. Mannan-binding lectin deficiency increases the risk of recurrent infections in children with Down's syndrome. Hum Immunol 2010; 71:63-6.
58. Arron JR, Winslow MM, Polleri A etal. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 2006; 441:595-600.
59. Kim YS, Cho KO, Lee HJ, Kim SY, Sato Y, Cho YJ. Down syndrome candidate region 1 increases the stability of the IkappaBalpha protein: implications for its anti-inflammatory effects. J Biol Chem 2006; 281:39051-61.
60. Lott I. Down syndrome, aging and Alzheimer's disease: a clinical review. Ann NY Acad Sci 1982; 396:15-27.
61. Cossariza A, Monti D, Montagnani G etal. Precocious aging of the immune system in Down syndrome: alteration of B-lymphocyte, T lymphocytes subsets, and cells with natural killer markers. Am J Med Genet Suppl 1990; 7:213-18.
62. Cuadrado E, Barrena M. Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol 1996; 78:209-14.
63. Licastro F, Chiricolo M, Mocchegiani E etal. Oral zinc supplementation in Down's syndrome subjects decreased infections and normalized some humoral and cellular immune parameters. J Intellect Disabil Res 1994; 38:149-62.
64. Stabile A, Pesaresi MA, Stabile AM etal. Immunodeficiency and plasma zinc levels in children with Down's syndrome: a long-term follow-up of oral zinc supplementation. Clin Immunol Immunopathol 1991; 58:207-16.
65. Lockitch G, Puterman M, Godolphin W, Sheps S, Tingle AJ, Quigley G. Infection and immunity in Down syndrome: a trial of long-term low oral doses of zinc. J Pediatr 1989; 114:781-7.
66. Mannan SE, Yousef E, Hossain J. Prevalence of positive skin prick test results in children with Down syndrome: a case-control study. Ann Allergy Asthma Immunol 2009; 102:205-9.
67. Bertrand P, Navarro H, Caussade S, Holmgren N, Sanchez I. Airway anomalies in children with Down syndrome: endoscopic findings. Pediatr Pulmonol 2003; 36:137-40.
68. Cooney TP, Thurlbeck WP. Pulmonary hypoplasia in Down's syndrome. N Engl J Med 1982; 307:1170-3.
69. Schloo BL, Vawter GF, Reid LM. Down syndrome: patterns of disturbed lung growth. Hum Pathol 1991; 22:919-23.
70. Dyken ME, Lin-Dyken DC, Poulton S, Zimmerman MB, Sedars E. Prospective polysomnographic analysis of obstructive sleep apnea in Down syndrome. Arch Pediatr Adolesc Med 2003; 257:655-60.
71. Marcus CL, Keens TG, Bautista DB, von Pechmann WS, Ward SL. Obstructive sleep apnea in children with Down syndrome. Pediatrics 1992; 88:132-9.
72. Jacobs IN, Gray RF, Todd NW. Upper airway obstruction in children with Down syndrome. Arch Otolaryngol Head Neck Surg 1996; 122:945-50.
73. Sheikh S, Allen E, Shell R etal. Chronic aspiration without gastroesophageal reflux as a cause of chronic respiratory symptoms in neurologically normal infants. Chest 2001; 120:1190-95.
74. Sheikh S, Stephen T, Howell L, Eid N. Gastroesophageal reflux in infants with wheezing. Pediatr Pulmonol 1999; 28:181-6.
75. Morton RE, Wheatley R, Minford J. Respiratory tract infections due to direct and reflux aspiration in children with severe neurodisability. Dev Med Child Neurol 1999; 41:329-34.
76. Frazier JB, Friedman B. Swallow function in children with Down syndrome: a retrospective study. Dev Med Child Neurol 1996; 38:695-703.
77. Brumbaugh DE, Accurso FJ. Persistent silent aspiration in a child with trisomy 21. Curr Opin Pediatr 2002; 14:231-3.
78. Weir K, McMahon S, Barry L, Ware R, Masters IB, Chang AB. Oropharyngeal aspiration and pneumonia in children. Pediatr Pulmonol 2007; 42:1024-31.
79. Zarate N, Mearin F, Hidalgo A, Malageada JR. Prospective evaluation of esophageal motor dysfunction in Down syndrome. Am J Gastroentrol 2001; 96:1718-24.
80. Frazier JB, Friedman B. Swallow function in children with Down syndrome: a retrospective study. Dev Med Child Neurol 1996; 38:695-703.
81. Strome M. Down syndrome - a modern otorhinolaryngological perspective. Layngoscope 1982; 41:1581-94.
82. Shott SR. Down syndrome: common otolaryngoloic manifestations. Am J Med Genet Part C Semin Med Genet 2006; 142:131-40.
83. Shibahara Y, Sando I. Congenital anomalies of the Eustachian tube in children with Down syndrome. Ann Otol Rhinol Laryngol 1989; 98:543-7.
84. Balkany TJ, Mischke RE, Downs MP, Jafek BW. Ossicular abnormalities in Down's syndrome. Otolaryngol Head Neck Surg 1979b; 87:372-4.